newsfilter
← Latest News
ACCESS Newswire·

Lexaria Discusses Valuation Metrics for Biotech Industry

Third Party Analysis for Biotech and Pharma Industries KELOWNA, BC / ACCESSWIRE / August 11, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is providing the follow